Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug-exposed neonates.

G Hoegerman1, C A Wilson, E Thurmond

  • 1Department of Medicine, Medical College of Virginia Hospitals, Virginia Commonwealth University, Richmond.

The Western Journal of Medicine
|May 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Stakeholder Support for Regulatory Harmonization and Expanded Nuclear Power: Outcomes of HPS/NCRP Open Forums.

Health physics·2026
Same author

Challenges and opportunities of the COVID-19 pandemic for perinatal mental health care: a mixed-methods study of mental health care staff.

Archives of women's mental health·2021
Same author

Increased risk of postpartum depression following severe obstetric lacerations in women with low resilience.

BJOG : an international journal of obstetrics and gynaecology·2020
Same author

Data for semi-permanent cationic coating for protein separations.

Data in brief·2020
Same author

Is there an increased risk of perinatal mental disorder in women with gestational diabetes? A systematic review and meta-analysis.

Diabetic medicine : a journal of the British Diabetic Association·2019
Same author

Reproductive success, spontaneous embryo abortion, and genetic load in flowering plants.

Oecologia·2017

Drug use in pregnancy harms perinatal outcomes, causing growth issues and birth defects. It also increases risks of preterm labor and human immunodeficiency virus (HIV) infection for mothers and infants.

Area of Science:

  • Obstetrics and Gynecology
  • Neonatology
  • Public Health

Background:

  • Drug use during pregnancy poses significant risks to both mother and fetus.
  • Adverse outcomes range from nonspecific effects like growth retardation to specific congenital anomalies.
  • Increased rates of preterm labor and human immunodeficiency virus (HIV) transmission are critical concerns.

Purpose of the Study:

  • To summarize the detrimental effects of maternal drug use on perinatal outcomes.
  • To highlight specific and nonspecific consequences for fetal development and infant health.
  • To underscore the rising incidence of HIV infection associated with drug abuse in pregnant populations.

Main Methods:

  • Review of existing literature on drug use in pregnancy.

Related Experiment Videos

  • Analysis of reported perinatal outcomes associated with various substances.
  • Examination of epidemiological data on HIV transmission in this demographic.

    • Main Results:

    • Maternal drug use is linked to fetal growth retardation, smaller infant size, and reduced head circumference.
    • Specific effects include facial dysmorphology and organ system anomalies, exemplified by alcohol-related birth defects.
    • Drug abuse elevates the risk of preterm labor and increases mother-to-infant HIV transmission rates.

    Conclusions:

    • Drug use during pregnancy leads to a spectrum of adverse perinatal outcomes.
    • Interventions are crucial to mitigate risks of developmental anomalies, preterm birth, and infectious diseases.
    • Public health strategies must address the increasing burden of HIV among drug-using pregnant individuals and their newborns.